Mode
Text Size
Log in / Sign up

Keratitis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Keratitis

6 trials tracked for Keratitis: 5 in phase 3 or 4 and 1 with published results. The most-cited published study has 12 citations.

6Trials tracked
5Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 3 Phase 3 2 Phase 2 1
  1. Phase 4 Impact of Acthar on Everyday Life of Participants With Severe Keratitis Completed · 12 cited
  2. Phase 4 Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses Completed
  3. Phase 4 Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis Completed
  4. Phase 3 Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer Completed
  5. Phase 3 Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis Completed
  6. Phase 2 Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.